This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Illumina Introduces Nextera® XT DNA Sample Preparation Kits

Stocks in this article: ILMN

Illumina (NASDAQ:ILMN) today introduced the Nextera XT DNA Sample Preparation Kit, the easiest way for researchers to prepare and sequence small genomes, PCR amplicons, and plasmids. When paired with Illumina’s MiSeq system, Nextera XT provides the fastest time to result of any next-generation sequencing technology currently available, enabling researchers to go from genomic DNA to analyzed data in less than 8 hours.

Nextera is the industry’s fastest sequencing sample preparation technology, with a simple assay that fragments DNA and inserts sequencing adapters and barcodes, all in a single tube. Nextera XT builds on this foundation with its cost-effective and improved workflow. The kit’s innovative sample normalization procedure eliminates the need for library quantitation prior to sample pooling and sequencing.

“Whether you are sequencing bacterial or viral genomes, plasmids, or PCR amplicons, the Nextera XT DNA Sample Preparation kit delivers the fastest time to answer,” said Christian Henry, Senior Vice President and General Manager of Illumina’s Genomic Solutions Business. “Researchers will easily and cost-effectively be able to prepare a large number of amplicons by simultaneously pooling and preparing them with Nextera XT. Up to 96 samples can then be combined and rapidly sequenced to enable flexible and scalable study design.”

Additionally, Nextera XT DNA Sample Preparation Kits offer unique benefits to researchers including:

  • Support for both the MiSeq and HiSeq® sequencing platforms
  • Integrated barcodes to support up to 96 samples per MiSeq run; up to 1,536 samples per HiSeq 2000 run; and, up to 384 samples per HiSeq 2500 run in rapid run mode
  • A 90-minute total sample preparation workflow, with the ability to manually process up to 900 samples per week

“Nextera XT made transitioning our targeted HIV amplicon sequencing experiments to the MiSeq system extremely easy,” said Dr. Jacques Corbeil from the Infectious Disease Research Center in Quebec and Canada Research Chair in Medical Genomics. “The output of the MiSeq system helps us screen many more samples rapidly, and its high-quality data enables us to detect low-frequency HIV variants.”

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs